Retinoblastoma screening rules set foundation for care
Ophthalmology can 'adopt' technologies from other specialties
7 pearls for beginning and seasoned surgeons
Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%
ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Bascom Palmer tops in annual program survey
Treating dry eye with recombinant human nerve growth factor
A new therapy is being investigated in a phase IIb trial to test its safety and effectiveness in patients with moderate-to-severe dry eye disease.
Weigh risks, benefits of cataract surgery for your patients
Liquid biopsies: Not yet ready for prime time in uveal melanoma
Gene therapy for LHON: Deciphering phase III data
Phase III studies of a gene therapy for Leber Hereditary Optic Neuropathy have generated some unexpected positive findings. There is biologic plausibility to explain the data.
Budding technology could be an OCT analysis game-changer
Tools for higher-order OCT assessment enable evaluation of features of interest, such as targeted retinal layers or fluid compartments, and may allow for unique characterization of disease phenotypes and treatment response.
Migraines, retinal perfusion: Pain for physicians, patients
OCT-A detected microcirculatory disturbances during acute post-aural migraine attacks may be an important tool in elucidating the pathophysiological relationship between migraine, aura, and ischemia.
Understand the expanding role of IPL in dry eye disease
Surgeons explore dropless for cataract surgery
Study targets NSAID use
FILLY study crosses goal with drop in geographic atrophy
The results of the phase II FILLY study are in agreement with the prior literature on risk factors for GA progression.
Teleglaucoma lets patients be more engaged in care
2019 Resident Writers Award Program
Quieting the neuropathic components of ocular pain
Nerve blocks have been found to be a useful option for patients dealing with chronic issues, giving physicians another treatment choice.
The 'age' game
When considering surgey, does a patient's age really matter?
Don’t split hairs when it comes to subspecialties
New battles taking shape in fight to control drug costs
Escalating prices continue to be an issue for patients. They also hamper treatment options for physicians.
10 effective habits of a cataract surgeon
From the Hill: Regulatory update
Drug costs, and other issues important to ophthalmologists, are in the cross-hairs of D.C. legislators.
Study targets therapies for endophthalmitis
Study evaluates novel and traditional antifungal agents to determine efficacy.
Study uncovers dispensaries in recommending marijuana for glaucoma treatment
Employees of medical marijuana dispensaries advocate drug’s benefits, contradicting the position of the American Glaucoma Society.
Glasses eyed as treatment in children
Pairing anti-inflammatory, mydriatic may reduce CME
Research shows small-aperture IOL is bringing stability into focus
Technology makes physicians more efficient, reduces burnout
New battles taking place in fight to control drug costs
